Your browser doesn't support javascript.
COVID-19: A review of therapeutic strategies and vaccine candidates.
Izda, Vladislav; Jeffries, Matlock A; Sawalha, Amr H.
  • Izda V; Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, OK, United States of America.
  • Jeffries MA; Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, OK, United States of America; University of Oklahoma Health Sciences Center, Department of Internal Medicine, Division of Rheumatology, Immunology, and Allergy, Oklahoma City, OK, United States of America. Electronic address: Matlock-Jeffries@omrf.org.
  • Sawalha AH; University of Pittsburgh, Departments of Pediatrics, Medicine, and Immunology, and Lupus Center of Excellence, Pittsburgh, PA, United States of America.
Clin Immunol ; 222: 108634, 2021 01.
Article in English | MEDLINE | ID: covidwho-1064947
ABSTRACT
The world is engulfed by one of the most widespread and significant public health crises in decades as COVID-19 has become among the leading causes of death internationally. The novel SARS-CoV-2 coronavirus which causes COVID-19 has unified the scientific community in search of therapeutic and preventative solutions. The top priorities at the moment are twofold first, to repurpose already-approved pharmacologic agents or develop novel therapies to reduce the morbidity and mortality associated with the ever-spreading virus. Secondly, the scientific and larger pharmaceutical community have been tasked with the development, testing, and production of a safe and effective vaccine as a longer-term solution to prevent further spread and recurrence throughout the populace. The purpose of this article is to review the most up-to-date published data regarding both the leading pharmacological therapies undergoing clinical trials and vaccine candidates in development to stem the threat of COVID-19.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Clin Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: J.clim.2020.108634

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Clin Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: J.clim.2020.108634